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Patient 1
Non-healing acral lesions often require amputation, and the recurrence of 
lesions can be problematic, necessitating vigilant monitoring.
Introduction
Calciphylaxis (calcific uraemic 
arteriolopathy - CUA) involves life-
threatening calcification of arterioles 
leading to necrotic infarcts of the skin 
and subcutaneous tissue (panniculus 
adiposus), erythema and livedo
reticularis, followed by painful, pre-
ulcerative, subcutaneous plaques with 
surrounding pruritic areas. These areas 
ulcerate revealing regions of necrotic 
subcutaneous adipose tissue covered 
by eschars with high potential for 
infectious complication.
The incidence of calciphylaxis is 
approximately 4.1% in patients on 
dialysis, with the reported incidence 
increasing over the past decade1,2,3. It 
is associated with significant morbidity 
and mortality, with limited studies 
suggesting a one year cause-specific 
mortality of 54.2%2. However, it is our 
experience that early diagnosis and 
increasing expertise has significantly 
improved the course of recovery for 
these patients.
Classically, calciphylaxis has been 
considered a disease of patients with 
advanced or end-stage renal disease. 
However, calciphylaxis in patients with 
near-normal renal function may not be 
as rare as previously believed3,4,5, 
therefore patients may present to 
dermatology after referral from primary 
care.
The table below outlines the risk factors 
for calciphylaxis present in these 
patients.
Patient 3
This patient had a personal history of calciphylaxis. Even still, the patient 
attributed the new lesions to scraping his leg, and the correct diagnosis was 
not reached for several weeks as the wounds failed to heal and the lesions 
occurred on the contralateral leg.
The presentation can be similar to peripheral vascular disease, which should 
be ruled out as an impediment to wound healing.
Conclusion and 
Recommendations
The rapid progression of calciphylaxis lesions highlights 
the need for swift response when the early signs appear. 
It is our experience that early diagnosis and increasing 
expertise has improved the course of recovery for these 
patients. The diagnostician must maintain a high degree 
of suspicion in at-risk patients. 
We have observed recurrence in several patients, 
indicating the importance of continued vigilance, even 
after successful treatment.
We suggest developing and maintaining a treatment 
algorithm that can be shared with the team involved in 
the care of patients with calciphylaxis, so that 
management is standardised and details are not 
forgotten or delayed.  Our approach includes the 
following measures: 
1. Cease vitamin D supplementation
2. Cease calcium supplementation
3. Cease warfarin (changing to another anticoagulant 
when necessary)
4. Intensive wound care, with judicious, limited 
debridement. 
5. Administer sodium thiosulfate with dialysis
6. Intensive dialysis with increased time and frequency
7. Consider parathyroidectomy if parathyroid hormone 
levels remain elevated
8. Intensive nutrition al supplementation including 
enteral tube feeding with broad vitamin, mineral, fat, 
and protein supplementation
9. Address peripheral vascular disease
10. Address analgesia
11. Administer antibiotics for infection, directed by 
proven microbiological sensitivity, when possible
With these measures, our experience is that the mortality 
rate in our patients has been much lower than historically 
quoted in studies. However, inpatient care rates are still 
very high and the disease course is often 6 to 12 months 
before resolution of open wounds occurs. It is our hope 
that continued research and experience will help to 
contribute to better courses and outcomes for patients 
with calciphylaxis.
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Patient 2
Judicious wound care and debridement is important in the healing process.
Contact
1. harrison.edwards@my.jcu.edu.au
2. cebarnes@kent.edu
Diagnosis Management
Patient 1
This patient’s lesions demonstrate acral necrosis, whereas the vast majority 
of lesions occur on the adipose tissue of the lower extremities and abdomen.
The varied clinical presentation of calciphylaxis (this patient was initially 
treated as having impetigo) highlights the importance of strong clinical 
suspicion.
Patient 2
The clinical presentation of calciphylaxis is varied and often appears benign. 
The lesions often begin as livedo reticularis or erythematous tender raised 
plaques. More advanced lesions develop central necrosis.
Patient 3
Resolution can take several months, which requires careful monitoring of the 
wounds in order to ensure the progression of healing and timely treatment of 
infection. This patient’s wounds were healed two months from the time of 
these photos.
Pt 1 Pt 2 Pt 3
Obesity X X X
Iron supplementation X
Corticosteroid X X
Diabetes X X
Vitamin D supplementation X X X
Peripheral Arterial Disease X X
Warfarin X X
High Calcium-Phosphorus Product X
Hyperparathyroidism X X X
Hypoalbuminaemia X
